Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Translational Oncology Research International.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Translational Oncology Research International
ClinicalTrials.gov Identifier:
NCT00203411
First received: September 13, 2005
Last updated: February 16, 2011
Last verified: February 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)